Berlin - Delayed Quote EUR

CEL-SCI Corp (LSRM.BE)

Compare
0.3470
+0.0006
+(0.17%)
At close: January 10 at 8:08:16 AM GMT+1
Currency in USD All numbers in thousands
Download
Breakdown
TTM
9/30/2023
9/30/2022
9/30/2021
9/30/2020
Operating Expense
27,699.5920
31,476.0740
36,062.7930
36,194.1290
28,985.0550
Operating Income
-27,699.5920
-31,476.0740
-36,062.7930
-36,194.1290
-28,985.0550
Net Non Operating Interest Income Expense
-752.9960
-675.4160
-1,081.0340
-1,149.2880
-1,041.7250
Other Income Expense
10.9110
-42.8130
443.1460
982.3080
-228.4640
Pretax Income
-28,441.6770
-32,194.3030
-36,700.6810
-36,361.1090
-30,255.2440
Net Income Common Stockholders
-29,101.1330
-32,365.8550
-37,629.8030
-36,711.9700
-30,276.9780
Average Dilution Earnings
--
--
--
-1,085.5400
--
Diluted NI Available to Com Stockholders
-29,101.1330
-32,365.8550
-37,629.8030
-37,797.5100
-30,276.9780
Basic EPS
-0.58
-0.73
-0.87
-0.90
-0.82
Diluted EPS
-0.58
-0.73
-0.87
-0.90
-0.82
Basic Average Shares
50,268.4090
44,479.8650
43,148.8880
40,662.1370
36,759.1150
Diluted Average Shares
50,268.4090
44,479.8650
43,148.8880
40,694.2480
36,759.1150
Total Operating Income as Reported
-27,699.5920
-31,476.0740
-36,062.7930
-36,194.1290
-28,985.0550
Total Expenses
27,699.5920
31,476.0740
36,062.7930
36,194.1290
28,985.0550
Net Income from Continuing & Discontinued Operation
-28,441.6770
-32,194.3030
-36,700.6810
-36,361.1090
-30,255.2440
Normalized Income
-28,441.6770
-32,194.3030
-37,067.4720
-37,351.6300
-29,100.4130
Interest Expense
752.9960
675.4160
1,081.0340
1,149.2880
1,041.7250
Net Interest Income
-752.9960
-675.4160
-1,081.0340
-1,149.2880
-1,041.7250
EBIT
-27,688.6810
-31,518.8870
-35,619.6470
-35,211.8210
-29,213.5190
EBITDA
-23,712.4250
-27,560.5530
-31,790.7300
-32,980.7130
-27,053.7900
Reconciled Depreciation
3,976.2560
3,958.3340
3,828.9170
2,231.1080
2,159.7290
Net Income from Continuing Operation Net Minority Interest
-28,441.6770
-32,194.3030
-36,700.6810
-36,361.1090
-30,255.2440
Total Unusual Items Excluding Goodwill
--
--
366.7910
990.5210
-1,154.8310
Total Unusual Items
--
--
366.7910
990.5210
-1,154.8310
Normalized EBITDA
-23,712.4250
-27,560.5530
-32,157.5210
-33,971.2340
-25,898.9590
9/30/2020 - 1/3/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

1K0.BE IGM Biosciences Inc. R
6.00
0.00%
 
1K0.F IGM Biosciences, Inc.
1.9000
-68.33%
 
1K0.MU IGM Biosciences Inc
4.8000
-21.31%
 
NFX.L Nuformix plc
0.0600
+26.32%
 
OBD.L Oxford BioDynamics Plc
0.9110
-8.90%
 
ATNFW 180 Life Sciences Corp.
0.0100
-4.76%
 
TCBPW TC Biopharm (Holdings) Plc
0.0150
+19.05%
 
CYCCP Cyclacel Pharmaceuticals, Inc.
7.60
-3.55%
 
SYBX Synlogic, Inc.
1.4701
+2.09%
 
PHGE BiomX Inc.
0.7624
+3.10%